These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20493413)

  • 1. Aspirin as antiplatelet agent in diabetes: Cons.
    Mannucci PM
    Eur J Intern Med; 2010 Jun; 21(3):154-6. PubMed ID: 20493413
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin as antiplatelet agent in diabetes. PROS-.
    Davì G; Santilli F
    Eur J Intern Med; 2010 Jun; 21(3):149-53. PubMed ID: 20493412
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin therapy in diabetes mellitus.
    Colwell JA
    Diabetologia; 1997 Jul; 40(7):867. PubMed ID: 9243111
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet agents and arterial thrombosis.
    Billett HH
    Cardiol Clin; 2008 May; 26(2):189-201, vi. PubMed ID: 18406994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Platelet aggregation inhibitors in diabetes mellitus].
    Abrahamian H
    Acta Med Austriaca; 1999; 26(5):137-41. PubMed ID: 11512189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further ex vivo evidence supporting higher aspirin dosing in patients with coronary artery disease and diabetes.
    Bliden KP; Tantry US; DiChiara J; Gurbel PA
    Circ Cardiovasc Interv; 2011 Apr; 4(2):118-20. PubMed ID: 21505165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations for peri-procedural thrombocyte aggregation inhibition].
    Sauer H; Leschke M
    Dtsch Med Wochenschr; 2006 Feb; 131(8):400-2. PubMed ID: 16479474
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
    Walker CW; Dawley CA; Fletcher SF
    Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin for primary prevention of cardiovascular events in people with diabetes.
    Pignone M; Alberts MJ; Colwell JA; Cushman M; Inzucchi SE; Mukherjee D; Rosenson RS; Williams CD; Wilson PW; Kirkman MS; ; ;
    J Am Coll Cardiol; 2010 Jun; 55(25):2878-86. PubMed ID: 20579547
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.
    Angiolillo DJ; Bernardo E; Capodanno D; Vivas D; Sabaté M; Ferreiro JL; Ueno M; Jimenez-Quevedo P; Alfonso F; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2010 Mar; 55(11):1139-46. PubMed ID: 20223369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
    Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
    Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleeding complications related to aspirin dose.
    Laine L; McQuaid K
    Am J Cardiol; 2005 Oct; 96(7):1035-6. PubMed ID: 16188542
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of aspirin in diabetic patients].
    Türkoğlu S; Abaci A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():5-8. PubMed ID: 18160360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of aspirin resistance in type 2 diabetes.
    Singla MK; Lahiri P; Mukhopadhyay P; Pandit K; Chaudhuri U; Chowdhury S
    J Indian Med Assoc; 2008 Nov; 106(11):720, 722-3, 740. PubMed ID: 19368097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments in response to "Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials".
    Fisher M; Knappertz V
    Am J Cardiol; 2005 Nov; 96(10):1467. PubMed ID: 16275203
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial.
    Serebruany VL; Malinin AI; Pokov A; Barsness G; Hanley DF
    Am Heart J; 2008 Jan; 155(1):93.e1-7. PubMed ID: 18082496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulants and antiplatelet therapy: 2012 update.
    Cummins D
    J Ark Med Soc; 2012 Aug; 109(2):39. PubMed ID: 22984709
    [No Abstract]   [Full Text] [Related]  

  • 18. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
    Moussa ID; Colombo A
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Platelet function inhibitors as a way of arterial thrombosis prevention in the diabetic].
    Lecompte T
    Journ Annu Diabetol Hotel Dieu; 2001; ():197-220. PubMed ID: 11565463
    [No Abstract]   [Full Text] [Related]  

  • 20. [Do all the patients with adult-onset diabetes mellitus need acetylsalicylic acid?].
    Lassila R
    Duodecim; 1999; 115(10):1174-7. PubMed ID: 11877857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.